Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Hans Hölschermann"'
Autor:
Bernhard Schieffer, Michael Worsch, Behnoush Parviz, Mariana S. Parahuleva, Hans Hölschermann, Michael Klassen
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND Factor VII-activating protease (FSAP) has a role in vascular inflammation and may have a role coronary artery disease (CAD). The aim of this study was to investigate the association between two naturally occurring single nucleotide polymor
Autor:
Christian Foerch, Marion Niessner, Florian Seeger, Hans Hölschermann, Tibo Gerriets, Volker Lischke, Kirsten Helwig
Publikováno v:
Neurocritical Care. 27:68-74
The neurological prognosis of patients after cardiopulmonary resuscitation (CPR) is difficult to assess. GFAP is an astrocytic intermediate filament protein released into bloodstream in case of cell death. We performed a prospective study aiming to c
Autor:
Mariana S. Parahuleva, Christoph Lipps, Behnoush Parviz, Hans Hölschermann, Bernhard Schieffer, Rainer Schulz, Gerhild Euler
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
MicroRNA (miR) is reported to be involved in vascular inflammation and may represent a novel class of diagnostic biomarkers in cardiovascular disease. We aimed to identify the miR expression profile in human advanced coronary atherosclerotic plaques
Autor:
Ali Erdogan, Nikoleta Parahuleva, Eva Langanke, Mehmet Burgazli, M Mericliler, Oliver Dörr, Behnoush Parviz, Hans Hölschermann, Mariana S. Parahuleva
Publikováno v:
Thrombosis Research. 135:260-266
Atherosclerosis, as an inflammatory disease, is characterized by pathologically altered levels of cytokines. We investigated whether smoking and/or oral contraceptives (OCs) affect the CD40/CD40L plasma levels and expression in young females without
Autor:
Andreas Böning, Michael Worsch, Daniel Zandt, Norbert Güttler, Harald Tillmanns, Ali Erdogan, Sandip M. Kanse, Hans Hölschermann, Mariana S. Parahuleva, Kirila Zheleva, Behnoush Parviz
Publikováno v:
Journal of Thrombosis and Thrombolysis. 37:317-325
Factor VII Activating Protease (FSAP) activates factor VII (FVII) as well as pro-urokinase (uPA). Our goal was to evaluate the relation between plasma levels of FSAP and clinical instability in atrial fibrillation (AF) and possible effects of oral om
Autor:
T.H.W Stadlbauer, Harald Tillmanns, Horst Fingerhuth, Rainer M. Bohle, Markus Hecker, Hans Hölschermann, Sandra Fiedel, Andreas H. Wagner
Publikováno v:
Cardiovascular Research. 79:698-705
Aims Cardiac allograft vasculopathy (CAV) continues to be an unsolved clinical problem requiring the development of new therapeutic strategies. We have previously demonstrated that ex vivo donor allograft treatment with decoy oligodeoxynucleotides (O
Autor:
Behnoush Parviz, Harald Tillmanns, Andreas Barth, Rainer M. Bohle, Sandip M. Kanse, Hans Hölschermann, Mariana S. Parahuleva, Daniel Sedding
Publikováno v:
Atherosclerosis. 196:164-171
The Factor Seven Activating Protease (FSAP) is known to influence fibrinolysis and to play a critical role in the inhibition of vascular smooth muscle cell (VSMC) proliferation and migration as well as neointima formation. In order to define the role
Autor:
Holger Hackstein, Hans Hölschermann, T.H.W. Stadlbauer, S. Fiedel, V. Rathke, Gregor Bein, Timucin Taner, Angus W. Thomson, A. Eisele, C. Steinschulte, Harald Tillmanns
Publikováno v:
American Journal of Transplantation. 7:789-798
Sanglifehrin A (SFA) is a novel compound with unsurpassed cyclophilin-binding affinity, but relatively low direct antilymphocytic activity. Here, we report the capacity of SFA to selectively inhibit key dendritic cell (DC) functions in vivo and to su
Autor:
Albrecht Elsässer, D. G. Mathey, Birgit Assmus, Jiangtao Yu, Volker Schächinger, Tim Suselbeck, Roberto Corti, Torsten Tonn, Sandra Erbs, Werner Haberbosch, Andreas M. Zeiher, Rainer Hambrecht, Christian W. Hamm, Hans Hölschermann, Stefanie Dimmeler
Publikováno v:
New England Journal of Medicine. 355:1210-1221
Background Pilot trials suggest that the intracoronary administration of autologous progenitor cells may improve left ventricular function after acute myocardial infarction. Methods In a multicenter trial, we randomly assigned 204 patients with acute
Autor:
Heidrun Muth, Song Rong, Harald Tillmanns, Markus Hecker, Horst Fingerhuth, Andreas H. Wagner, T.H.W Stadlbauer, Faikah Güler, Hans Hölschermann
Publikováno v:
Cardiovascular Research. 71:527-536
Objective: Acute myocardial rejection is a cell-mediated process characterized by increased leukocyte recruitment into the graft myocardial tissue. Transcription factors like STAT-1 and AP-1 are critically involved in this process by regulating vascu